← Eichor
Study identifier: NCT02127398 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Stool Transplants to Treat Refractory Clostridium Difficile Colitis

Condition: Clostridium Difficile Colitis  ·  Sponsor: Duke University

PhasePhase 2
Planned participants77
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

It has been shown that restoration of the normal makeup of the bowel bacterial population is the most effective way to treat recurrent colitis due to Clostridium difficile. Restoration of the normal bowel bacterial population is best done by transplanting stool from a healthy donor. The investigators wish to transplant stool from healthy donors to treat recurrent C. difficile colitis by incorporating the stool into capsules that are administered by the oral route.

This description comes directly from the study's public registry record.

Talk to the study team

Gary M Cox, MD  ·  919-668-3271  ·  gary.cox@duke.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Duke University Medical CenterDurham, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02127398